Brief: Illumina Expands Clinical Oncology Portfolio Unlocking New Standard Of Care And Access To Precision Therapies
28/05/2025 15:49
May 28 (Reuters) - Illumina Inc ILMN.O: ILLUMINA EXPANDS CLINICAL ONCOLOGY PORTFOLIO UNLOCKING NEW STANDARD OF CARE AND ACCESS TO PRECISION THERAPIES Source text: ID:nPn9bxnDda Further company coverage: ILMN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Illumina
See all newsBrief: Illumina Bioinsight Platform Expands With New Software To Accelerate The Path From Sequencing To Discovery
US RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Brief: Illumina - Establishes Unsecured Commercial Paper Program On October 8, 2026
Brief: Illumina To Announce Third Quarter 2026 Financial Results
Brief: Illumina Releases Spliceai2 To Help Advance Rare Disease Research